Simvastatin impairs mitogen-induced proliferation of malignant B- lymphocytes from humans-in vitro and in vivo studies

Lipids

Volumn 32, Issue 3, 1997, Pages 255-262

  Vitols, S ^a   Angelin, B ^a   Juliusson, G ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVINOLIN; MITOGENIC AGENT; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MALE; ORAL DRUG ADMINISTRATION;

ADULT; AGED; ANTILIPEMIC AGENTS; B-LYMPHOCYTES; CELL DIVISION; CHOLESTEROL; CHRONIC DISEASE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKEMIA, LYMPHOCYTIC; LIPIDS; LIPOPROTEINS, LDL; LOVASTATIN; MALE; MIDDLE AGED; MITOGENS; PRAVASTATIN; SIMVASTATIN; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0030978664     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-997-0032-1     Document Type: Article

References (27)

1. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N., and Pasternack, B.S. (1975) Clinical Staging of Chronic Lymphocytic Leukemia, Blood 46, 219-234.
2. Goldstein, J.L., and Brown, M.S. (1977) The Low-Density Lipoprotein Pathway and Its Relation to Atherosclerosis, Ann Rev. Biochem. 46, 897-930.
3. Ho, Y., Smith, G., Brown, M., and Goldstein, J. (1978) Low Density Lipoprotein (LDL) Receptor Activity in Human Acute Myelogenous Leukemia Cells, Blood 52, 1099-1114.
4. Vitols, S., Gahrton, G., Öst, Å., and Peterson, C. (1984) Elevated Low Density Lipoprotein Receptor Activity in Leukemic Cells with Monocytic Differentiation, Blood 63, 1186-1193.
5. Juliusson, G., and Vitols, S. (1988) Impaired Low-Density Lipoprotein Receptor Activity in Chronic B-Lymphocytic Leukaemia Cells, Eur. J. Haematol. 40, 18-24.
6. Harwood, H.J., Alvarez, I.M., Noyes, W.D., and Stacpoole, P.W. (1991) In vivo Regulation of Human Leukocyte 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase: Increased Enzyme Protein Concentration and Catalytic Efficiency in Human Leukemia and Lymphoma, J. Lipid. Res. 32, 1237-1252.
7. Havel, R.J., Eder, H.A., and Bragdon, J.H. (1955) The Distribution and Chemical Composition of Ultracentrifugally Separated Lipoproteins in Human Serum, J. Clin. Invest. 34, 1345-1353.
8. Langer, T., Strober, W., and Levy, R.I. (1972) The Metabolism of Low Density Lipoprotein in Familial Type II Hyperlipoproteinemia, J. Clin. Invest. 51, 1528-1536.
9. Goldstein, J.L., Basu, S.K., and Brown, M.S. (1983) Receptor-Mediated Endocytosis of Low-Density Lipoprotein in Cultured Cells, Methods Enzymol. 98, 241-260.
10. Lowry, U.H., Rosenbrough, N.J., Farr, A.L., and Randall, R.I. (1951) Protein Measurement with the Folin Phenol Reagent, J. Biol. Chem. 193, 265-275.
11. Carlson, K. (1973) Lipoprotein Fractionation, J. Clin. Pathol. Suppl. (Assoc. Clin. Pathol.) 5, 32-37.
12. Lopes, V.M., Stone, P., Ellis S., and Colwell, J.A. (1977) Cholesterol Determination in High-Density Lipoproteins Separated by Three Different Methods. Clin. Chem. 23, 882-884.
13. Robert, K.H. (1979) Induction of Monoclonal Antibody Synthesis in Malignant Human B Cells by Polyclonal B Cell Activators. Relationship Between B Cell Subsets and Prognosis, Immunol. Rev. 48, 123-143.
14. Gahrton, G., Robert, K.H., Friberg, K., Zech, L., and Bird, A.G. (1980) Nonrandom Chromosomal Aberrations in Chronic Lymphocytic Leukemia Revealed by Polyclonal B-Cell-Mitogen Stimulation, Blood 56, 640-647.
15. Robert, K.H., Juliusson, G., and Biberfeld, P. (1983) Chronic Lymphocytic Leukaemia Cells Activated in vitro Reveal Cellular Changes That Characterize B-Prolymphocytic Leukaemia and Immunocytoma, Scand. J. Immunol. 17, 397-401.
16. Juliusson, G., Robert, K.H., Hammarstrom, L., Smith, C.I., Biberfeld, G., and Gahrton, G. (1983) Mitogen-Induced Switching of Immunoglobulin Heavy-Chain Class Secretion in Chronic B-Lymphocytic Leukaemia and Immunocytoma Cell Populations, Scand. J. Immunol. 17, 51-59.
17. Vitols, S., Norgren, S., Juliusson, G., Tatidis, L., and Luthman, H. (1994) Multilevel Regulation of Low-Density Lipoprotein Receptor and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Gene Expression in Normal and Leukemic Cells, Blood 84, 2689-2698.
18. Cuthbert, J.A., and Lipsky, P.E. (1990) Inhibition by 6-Fluoromevalonate Demonstrates That Mevalonate or One of the Mevalonate Phosphates Is Necessary for Lymphocyte Proliferation, J. Biol. Chem. 265, 18568-18575.
19. Sumi, S., Beauchamp, R.D., Townsend, C.J., Uchida, T., Murakami, M., Rajaraman, S., Ishizuka, J., and Thompson, J.C. (1992) Inhibition of Pancreatic Adenocarcinoma Cell Growth by Lovastatin, Gastroenterology 103, 982-989.
20. Maltese, W.A., Defendini, R., Green, R.A., Sheridan, K.M., and Donley, D.K. (1985) Suppression of Murine Neuroblastoma Growth in vivo by Mevinolin, a Competitive Inhibitor of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase, J. Clin. Invest. 76, 1748-1754.
21. Newman, A., Clutterbuck, R.D., Powles, R.L., and Millar, J.L. (1994) Selective Inhibition of Primary Acute Myeloid Leukaemia Cell Growth by Simvastatin, Leukemia 8, 2023-2029.
22. Ruch, R.J., Madhukar, B.V., Trosko, J.E., and Klaunig, J.E. (1993) Reversal of Ras-Induced Inhibition of Gap-Junctional Intercellular Communication, Transformation, and Tumorigenesis by Lovastatin, Mol. Carcinog. 7, 50-59.
23. Schafer, W.R., Kim, R., Sterne, R., Thorner, J., Kim, S.H., and Rine, J. (1989) Genetic and Pharmacological Suppression of Oncogenic Mutations in Ras Genes of Yeast and Humans, Science 245, 379-385.
24. Butturini, A., and Gale, R.P. (1988) Oncogenes in Chronic Lymphocytic Leukemia, Leuk. Res. 12, 89-92.
25. Thibault, A., Samid, D., Tompkins, A.C., Figg, W.D., Cooper, M.R., Hohl, R.J., Trepel, J., Liang, B., Patronas, N., Venzon, D.J., Reed, E., and Myers, C.E. (1996) Phase I Study of Lovastatin, An Inhibitor of the Mevalonate Pathway, in Patients with Cancer, Clinical Cancer Res. 2, 483-491.
26. The Scandinavian Simvastatin Survival Study Group (1994) Randomised Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S), Lancet 344, 1383-1389.
27. Todd, P.A., and Goa, K.L. (1990) Simvastatin. A Review of Its Pharmacological Properties and Therapeutic Potential in Hypercholesterolaemia, Drugs 40, 583-607.